Table 1.
Mitochondrial Thiols and Related Enzymatic Systems in Disease
Thiols involved | References | |
---|---|---|
Neurodegeneration | ||
Models of Alzheimer's disease | Prx3, GSH | 16, 55, 91 |
Models of Parkinson's disease | Grx1*, Grx2, GSH, Protein-SSG, Prx3, Prx5 | 27, 44, 55, 60, 94, 98, 125, 155 |
Excitotoxicity | Prx3 | 60 |
Down syndrome | Prx3 | 91, 94 |
Liver diseases | ||
Alcohol-induced hepatoxicity | Srx | 9 |
Alcoholic steatohepatitis | GSH | 33, 105, 201, 202 |
Nonalcoholic steatohepatitis | GSH | 109 |
Chronic alcoholism | GSH | 50 |
Acetaminophen toxicity | GSH | 179, 201 |
Liver cirrhosis | GSH | 93 |
Cardiovascular diseases | ||
Ischemic preconditioning | Protein-SSG, Protein-SNO | 24, 62 |
Dilated cardiomyopathy | TrxR2 | 160 |
Myocardial infarction | Prx3 | 7 |
Vascular muscle function | Protein-SSG | 63 |
Diabetes | ||
Glucose tolerance | Prx3 | 21 |
Diabetic retinopathy | GSH | 86 |
Cancer | ||
Hepatocellular carcinomas | TrxR2, Prx3 | 29 |
Human breast cancer | Prx3 | 129 |
Colon cancer cell protection | Prx3 | 131 |
Neoplastic transformation | Prx3 | 188 |
Aging | GSH, Prx5 | 43, 146, 165, 181 |
Stroke - Focal cerebral ischemia | GSH | 3, 163 |
The table summarizes the involvement of selective mitochondrial thiols in different disease models addressed in this review. *Glutaredoxin-1 in the inter-membrane space.